Tags: Drug.

Cobimetinib (GDC-0973 XL-518) is a MEK inhibitor being developed by Exelixis and Roche. It is being studied in combination with vemurafenib to treat several cancers including melanoma.

Cobimetinib.svg
ATC prefix
none
CAS number
934660-93-2
IUPAC name
[34-Difluoro-2-(2-fluoro-4-iodoanilino)phenyl]3-hydroxy-3-[(2S)-piperidin-2-yl]azetidin-1-yl methanone
PubChem
16222096

Loading...

This page contains content from the copyrighted Wikipedia article "Cobimetinib"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.